Canadian application, no grantCanada
A method for screening for autoimmune disease by identifying polymorphisms in il-12 p40
CA 2404493 A1 · Owner: Morahan, Grant · Inventors: Morahan, Grant
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of screening mammals for an autoimmune disease or a predisposition to said disease (e.g diabeties). The method consists of identifying polymorphisms in IL-12 p40 and linking them to the disease condition.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 27, 2001
GrantedNo grant recorded
Term endedMarch 27, 2021
Patent numberCA 2404493 A1
Classification (IPC)C12N15/24 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.